Activation of these transcription factors up-regulates autocrine IL-6 production, and expression of anti-apoptotic proteins Mcl-1 and Bcl-xL, leading to resistance of CLL cells to in vitro spontaneous apoptosis and chemotherapy. The gene discussed is BCL2L1; the disease is B-cell chronic lymphocytic leukemia.